Initial results are available from a study involving AtheroCare and cyclodextrin. The study had 50 participants and examined the effects of cyclodextrin.

Results show reductions in CAC, although further details are not provided here. For more information, readers can consult the source.

The study's findings may be of interest to those looking for updates on medical research involving cyclodextrin and AtheroCare.